In Depth 10 Jul 2023
Unleashing the potential: Optimizing mRNA for the discovery of transformative medicines
By Dr. Alexander Zehnder, CEO, CureVac The success of mRNA vaccines in COVID-19 propelled the role of this new modality to the forefront of medicine. Not only are new prophylactic…